Institut Claudius Regaud, IUCT-Oncopole

Toulouse 31059

0 studies enrolling now · 6 studies all time

What they study most

Advanced Cancer, Advanced Solid Tumor, Advanced Urothelial Carcinoma, Biliary Tract Neoplasms, Bladder Cancer, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Cutaneous Melanoma, Endometrial Neoplasms, FGFR3 Gene Alteration, FGFR3 Gene Mutation, HPV-Related Anal Squamous Cell Carcinoma

Studies at this site

• Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) — Running, not enrolling
• Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers — Running, not enrolling
• Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations — Running, not enrolling
• A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors — Completed
• A Study of LY3434172, a PD-1 and PD-L1 Bispecific Antibody, in Advanced Cancer — Stopped early
• PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma — Stopped early